Moreover, IL-6 activated stat3, increased stat3 phosphorylation, and inhibited the transcription and expression of zinc transporter SLC39A5, thereby increasing glucagon secretion and the risk of T2D (Chen et al., 2023). This evidence concerns the gene GCG and type 2 diabetes mellitus.